Ensuring Patient Adherence in Paediatric and Geriatric Populations

Pharmaceutical companies are increasingly adopting patient-centric formulation development to ensure that products adequately meet the needs of end-users in all target patient populations

Pharmaceutical companies today face higher hurdles than ever before in getting products to market. The patient, as the end-user, is now a force to be reckoned with as governments, payers, and healthcare providers around the world place increasing emphasis on patient outcomes. Patient noncompliance costs the pharmaceutical industry approximately US$330 billlion annually as a study conducte by MarketWatch reveals. With this new emphasis on patient centricity, the pharmaceutical industry has been quick to realize the importance of embracing the patient.

Read what HERMES PHARMA's Dr Martin Koebere and other industry experts discussed about this topic. (This feature has been written by Adeline Siew and published in Pharmaceutical Technology, November 2017).